COST-EFFECTIVENESS ANALYSIS OF TREATING ACUTE CORONARY SYNDROME PATIENTS WITH TICAGRELOR VERSUS CLOPIDOGREL IN HONG KONG: A MARKOV ANALYTIC MODEL

被引：0
|
作者：
Lee, V. W. Y. [1 ]
Chow, I. H. I. [1 ]
Yan, B. P. [2 ,3 ]
Yu, C. M. [1 ]
Lam, Y. Y. [1 ]
机构：
[1] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China
[2] Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China
[3] Monash Univ, Hong Kong, Hong Kong, Peoples R China
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.993
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A371 / A371
页数：1
相关论文
共 50 条
  • [11] Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany
    Ulrike Theidel
    Christian Asseburg
    Evangelos Giannitsis
    Hugo Katus
    Clinical Research in Cardiology, 2013, 102 : 447 - 458
  • [12] COST-EFFECTIVENESS OF TICAGRELOR IN PATIENTS WITH ACUTE CORONARY SYNDROME
    Kim, K.
    Calabrese, M.
    Lin, F. J.
    Ojo, O.
    Cavallari, L. H.
    Touchette, D. R.
    VALUE IN HEALTH, 2013, 16 (03) : A284 - A284
  • [13] A COST-EFFECTIVENESS ANALYSIS OF TICAGRELOR IN PATIENTS WITH ACUTE CORONARY SYNDROME IN GREECE
    Kritikou, P.
    Yfantopoulos, J.
    VALUE IN HEALTH, 2011, 14 (07) : A379 - A379
  • [14] Erratum to: Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany
    Ulrike Theidel
    Christian Asseburg
    Evangelos Giannitsis
    Hugo Katus
    Clinical Research in Cardiology, 2013, 102 (6) : 477 - 477
  • [15] COST-EFFECTIVENESS OF CYP2C19*2 GENOTYPE GUIDED SELECTION OF CLOPIDOGREL OR TICAGRELOR IN HONG KONG CHINESE PATIENTS WITH ACUTE CORONARY SYNDROME
    Lee, V. W.
    Wang, Y.
    Liew, D.
    Yan, B. P.
    VALUE IN HEALTH, 2016, 19 (07) : A811 - A811
  • [16] Cost-effectiveness of clopidogrel versus ticagrelor in patients of 70 years or older with non-ST-elevation acute coronary syndrome
    Van den Broek, W. W. A.
    Van Paassen, J. G.
    Gimbel, M. E.
    Deneer, V. H. M.
    Ten Berg, J. M.
    Vreman, R. A.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2846 - 2846
  • [17] COST ANALYSIS ON PRASUGREL/TICAGRELOR VERSUS CLOPIDOGREL AS PART OF DAPT IN HONG KONG POSTACS PATIENTS
    Lee, V
    Lam, A.
    Yan, B.
    VALUE IN HEALTH, 2020, 23 : S496 - S496
  • [18] Cost-Effectiveness of Ticagrelor Compared with Clopidogrel in Patients with Acute Coronary Syndrome from Vietnamese Healthcare Payers’ Perspective
    Thuy Thi Thu Nguyen
    Dung Van Do
    Carl Mellstrom
    Tuan Quang Nguyen
    Hung Manh Pham
    Sy Van Hoang
    Thinh Cong Luu
    Tri Le Phuong
    Advances in Therapy, 2021, 38 : 4026 - 4039
  • [19] Cost-Effectiveness of Ticagrelor Compared with Clopidogrel in Patients with Acute Coronary Syndrome from Vietnamese Healthcare Payers' Perspective
    Thuy Thi Thu Nguyen
    Dung Van Do
    Mellstrom, Carl
    Tuan Quang Nguyen
    Hung Manh Pham
    Sy Van Hoang
    Thinh Cong Luu
    Tri Le Phuong
    ADVANCES IN THERAPY, 2021, 38 (07) : 4026 - 4039
  • [20] COST-EFFECTIVENESS OF TICAGRELOR COMPARED WITH CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME FROM A VIETNAMESE HEALTHCARE PAYERS' PERSPECTIVE
    Do, V. D.
    Nguyen, T. T.
    Mellstrom, C.
    Nguyen, Q. T.
    Pham, M. H.
    Hoang, V. S.
    Phuong, L. T.
    Luu, T. C.
    VALUE IN HEALTH, 2018, 21 : S2 - S2
12345